ROSSETTOS NICHOLAS J 4
4 · MANHATTAN PHARMACEUTICALS INC · Filed Aug 19, 2005
Insider Transaction Report
Form 4
ROSSETTOS NICHOLAS J
Chief Financial Officer
Transactions
- Award
Stock Options
2005-01-11+50,000→ 50,000 totalExercise: $1.00Exp: 2015-01-11→ Common Stock (50,000 underlying)
Holdings
- 10,000
Stock Options
Exercise: $20.94Exp: 2010-04-12→ Common Stock (10,000 underlying) - 25,000
Stock Options
Exercise: $1.00From: 2002-03-28Exp: 2012-03-28→ Common Stock (25,000 underlying) - 150,000
Stock Options
Exercise: $1.65Exp: 2014-01-28→ Common Stock (150,000 underlying) - 292,030
Stock Options
Exercise: $0.40Exp: 2013-02-24→ Common Stock (292,030 underlying)
Footnotes (8)
- [F1](Right to buy)
- [F2]Currently exercisable.
- [F3]2,500 shares vest on each of 2/20/01, 2/20/02, 2/20/03 and 2/20/04.
- [F4]2,500 shares vest on each of 2/19/02, 2/19/03, 2/19/04 and 2/19/05.
- [F5]146,015 shares are currently vested; 146,015 shares vest on 2/24/05.
- [F6]Option vests on the earlier of FDA approval or Catarex or 2/19/07.
- [F7]50,000 shares vest on each of 1/28/04, 1/28/05 and 1/28/06.
- [F8]25,000 shares vest on each of 1/3/06 and 1/3/07.